Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Infectious Diseases Preliminary Screening Tests
1.2 Key Market Segments
1.2.1 Infectious Diseases Preliminary Screening Tests Segment by Type
1.2.2 Infectious Diseases Preliminary Screening Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Infectious Diseases Preliminary Screening Tests Market Overview
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Infectious Diseases Preliminary Screening Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Infectious Diseases Preliminary Screening Tests Market Competitive Landscape
3.1 Global Infectious Diseases Preliminary Screening Tests Sales by Manufacturers (2019-2024)
3.2 Global Infectious Diseases Preliminary Screening Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Infectious Diseases Preliminary Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Infectious Diseases Preliminary Screening Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Infectious Diseases Preliminary Screening Tests Sales Sites, Area Served, Product Type
3.6 Infectious Diseases Preliminary Screening Tests Market Competitive Situation and Trends
3.6.1 Infectious Diseases Preliminary Screening Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Infectious Diseases Preliminary Screening Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Infectious Diseases Preliminary Screening Tests Industry Chain Analysis
4.1 Infectious Diseases Preliminary Screening Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Infectious Diseases Preliminary Screening Tests Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Infectious Diseases Preliminary Screening Tests Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Type (2019-2024)
6.3 Global Infectious Diseases Preliminary Screening Tests Market Size Market Share by Type (2019-2024)
6.4 Global Infectious Diseases Preliminary Screening Tests Price by Type (2019-2024)
7 Infectious Diseases Preliminary Screening Tests Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Preliminary Screening Tests Market Sales by Application (2019-2024)
7.3 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Infectious Diseases Preliminary Screening Tests Sales Growth Rate by Application (2019-2024)
8 Infectious Diseases Preliminary Screening Tests Market Segmentation by Region
8.1 Global Infectious Diseases Preliminary Screening Tests Sales by Region
8.1.1 Global Infectious Diseases Preliminary Screening Tests Sales by Region
8.1.2 Global Infectious Diseases Preliminary Screening Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Infectious Diseases Preliminary Screening Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Infectious Diseases Preliminary Screening Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Infectious Diseases Preliminary Screening Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Infectious Diseases Preliminary Screening Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Infectious Diseases Preliminary Screening Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott
9.1.1 Abbott Infectious Diseases Preliminary Screening Tests Basic Information
9.1.2 Abbott Infectious Diseases Preliminary Screening Tests Product Overview
9.1.3 Abbott Infectious Diseases Preliminary Screening Tests Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 BD
9.2.1 BD Infectious Diseases Preliminary Screening Tests Basic Information
9.2.2 BD Infectious Diseases Preliminary Screening Tests Product Overview
9.2.3 BD Infectious Diseases Preliminary Screening Tests Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.2.6 BD Recent Developments
9.3 Bio-rad Laboratories, Inc
9.3.1 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.3.2 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.3.3 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.3.4 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests SWOT Analysis
9.3.5 Bio-rad Laboratories, Inc Business Overview
9.3.6 Bio-rad Laboratories, Inc Recent Developments
9.4 Cepheid
9.4.1 Cepheid Infectious Diseases Preliminary Screening Tests Basic Information
9.4.2 Cepheid Infectious Diseases Preliminary Screening Tests Product Overview
9.4.3 Cepheid Infectious Diseases Preliminary Screening Tests Product Market Performance
9.4.4 Cepheid Business Overview
9.4.5 Cepheid Recent Developments
9.5 Hologic Inc
9.5.1 Hologic Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.5.2 Hologic Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.5.3 Hologic Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.5.4 Hologic Inc Business Overview
9.5.5 Hologic Inc Recent Developments
9.6 Meridian Bioscience, Inc
9.6.1 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.6.2 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.6.3 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.6.4 Meridian Bioscience, Inc Business Overview
9.6.5 Meridian Bioscience, Inc Recent Developments
9.7 OraSure Technologies, Inc
9.7.1 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.7.2 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.7.3 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.7.4 OraSure Technologies, Inc Business Overview
9.7.5 OraSure Technologies, Inc Recent Developments
9.8 Quidel Corporation
9.8.1 Quidel Corporation Infectious Diseases Preliminary Screening Tests Basic Information
9.8.2 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Overview
9.8.3 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Market Performance
9.8.4 Quidel Corporation Business Overview
9.8.5 Quidel Corporation Recent Developments
9.9 F. Hoffmann-La Roche Ltd
9.9.1 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Basic Information
9.9.2 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Overview
9.9.3 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Market Performance
9.9.4 F. Hoffmann-La Roche Ltd Business Overview
9.9.5 F. Hoffmann-La Roche Ltd Recent Developments
9.10 BUREAU VERITAS
9.10.1 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Basic Information
9.10.2 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Overview
9.10.3 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Market Performance
9.10.4 BUREAU VERITAS Business Overview
9.10.5 BUREAU VERITAS Recent Developments
9.11 Eurofins Scientific
9.11.1 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Basic Information
9.11.2 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Overview
9.11.3 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Market Performance
9.11.4 Eurofins Scientific Business Overview
9.11.5 Eurofins Scientific Recent Developments
9.12 Siemens Healthcare Private Limited
9.12.1 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Basic Information
9.12.2 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Overview
9.12.3 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Market Performance
9.12.4 Siemens Healthcare Private Limited Business Overview
9.12.5 Siemens Healthcare Private Limited Recent Developments
9.13 Luminex Corporation
9.13.1 Luminex Corporation Infectious Diseases Preliminary Screening Tests Basic Information
9.13.2 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Overview
9.13.3 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Market Performance
9.13.4 Luminex Corporation Business Overview
9.13.5 Luminex Corporation Recent Developments
9.14 PerkinElmer Inc
9.14.1 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.14.2 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.14.3 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.14.4 PerkinElmer Inc Business Overview
9.14.5 PerkinElmer Inc Recent Developments
9.15 QIAGEN
9.15.1 QIAGEN Infectious Diseases Preliminary Screening Tests Basic Information
9.15.2 QIAGEN Infectious Diseases Preliminary Screening Tests Product Overview
9.15.3 QIAGEN Infectious Diseases Preliminary Screening Tests Product Market Performance
9.15.4 QIAGEN Business Overview
9.15.5 QIAGEN Recent Developments
9.16 Mesa Biotech
9.16.1 Mesa Biotech Infectious Diseases Preliminary Screening Tests Basic Information
9.16.2 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Overview
9.16.3 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Market Performance
9.16.4 Mesa Biotech Business Overview
9.16.5 Mesa Biotech Recent Developments
9.17 Illumina, Inc
9.17.1 Illumina, Inc Infectious Diseases Preliminary Screening Tests Basic Information
9.17.2 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Overview
9.17.3 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Market Performance
9.17.4 Illumina, Inc Business Overview
9.17.5 Illumina, Inc Recent Developments
10 Infectious Diseases Preliminary Screening Tests Market Forecast by Region
10.1 Global Infectious Diseases Preliminary Screening Tests Market Size Forecast
10.2 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country
10.2.3 Asia Pacific Infectious Diseases Preliminary Screening Tests Market Size Forecast by Region
10.2.4 South America Infectious Diseases Preliminary Screening Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Infectious Diseases Preliminary Screening Tests by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Infectious Diseases Preliminary Screening Tests by Type (2025-2030)
11.1.2 Global Infectious Diseases Preliminary Screening Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Infectious Diseases Preliminary Screening Tests by Type (2025-2030)
11.2 Global Infectious Diseases Preliminary Screening Tests Market Forecast by Application (2025-2030)
11.2.1 Global Infectious Diseases Preliminary Screening Tests Sales (K Units) Forecast by Application
11.2.2 Global Infectious Diseases Preliminary Screening Tests Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings